Screener
Ionis Pharmaceuticals IONS Available For Sale Securities Debt Securities Current
Available For Sale Securities Debt Securities Current at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| June 30, 2026 | Amortized / Cost | Gross Unrealized / Gains | Gross Unrealized / Losses | Estimated / Fair Value |
|---|---|---|---|---|
| Debt securities issued by U.S. government agencies | 26,439 | 26 | (20) | 26,445 |
| Debt securities issued by the U.S. Treasury (1) | 467,565 | 88 | (604) | 467,049 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 5,025 | - | (3) | 5,022 |
| Total debt securities with a maturity of one year or less | 1,137,717 | 425 | (1,101) | 1,137,041 |
| Corporate debt securities | 349,545 | 87 | (1,692) | 347,940 |
| Debt securities issued by U.S. government agencies | 119,701 | 4 | (878) | 118,827 |
| Debt securities issued by the U.S. Treasury | 181,168 | - | (1,340) | 179,828 |
| Debt securities issued by states of the U.S. and political subdivisions of the states | 731 | - | (1) | 730 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's available for sale securities debt securities current?
- Ionis Pharmaceuticals (IONS) reported available for sale securities debt securities current of $1.14B in Q2 2026.
- How has Ionis Pharmaceuticals's available for sale securities debt securities current changed year-over-year?
- Ionis Pharmaceuticals's available for sale securities debt securities current decreased by 14.5% year-over-year, from $1.33B to $1.14B.
- What is the long-term trend for Ionis Pharmaceuticals's available for sale securities debt securities current?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's available for sale securities debt securities current has grown at a 1.1% compound annual growth rate (CAGR), from $1.49B to $1.58B.
Ask your AI about Ionis Pharmaceuticals's available for sale securities debt securities current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude